Pharmena Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	37	43	79	62	88	99
Market Cap Growth	-29.64%	-46.06%	26.79%	-29.20%	-10.89%	67.91%
Enterprise Value	37	32	57	72	96	103
Last Close Price	3.30	3.83	6.41	5.05	7.14	8.12
PE Ratio	-	-	2.73	-	-	-
PS Ratio	28.85	159.17	264.48	208.60	5.79	9.95
PB Ratio	3.49	3.44	3.56	-9.18	-17.20	-284.09
P/TBV Ratio	3.99	3.78	3.53	-	-	-
P/FCF Ratio	-	-	2.42	39.15	-	-
P/OCF Ratio	-	-	2.39	34.29	-	-
EV/Sales Ratio	28.71	119.44	191.28	241.50	6.34	10.39
EV/EBITDA Ratio	-	-	1.74	-	-	-
EV/EBIT Ratio	-	-	1.74	-	-	-
EV/FCF Ratio	-12.83	-	1.75	45.33	-	-
Debt / Equity Ratio	0.02	0.02	0.01	-1.49	-1.90	-15.83
Debt / EBITDA Ratio	-	-	0.01	-	-	-
Debt / FCF Ratio	-	-	0.01	6.37	-	-
Net Debt / Equity Ratio	-0.02	-0.12	-0.99	-1.26	-1.61	-10.88
Net Debt / EBITDA Ratio	0.05	0.44	-0.67	-2.16	-2.14	-0.65
Net Debt / FCF Ratio	0.06	0.55	-0.67	5.37	-2.33	-1.54
Asset Turnover	0.11	0.01	0.02	0.03	1.38	0.88
Inventory Turnover	0.30	0.12	0.12	0.05	1.82	0.91
Quick Ratio	1.19	2.22	12.84	0.30	0.40	0.37
Current Ratio	13.52	12.98	13.17	0.59	0.71	0.74
Return on Equity (ROE)	-19.70%	-7.29%	350.10%	-	-	-299.40%
Return on Assets (ROA)	-17.02%	-11.30%	111.71%	-21.39%	-22.93%	-33.80%
Return on Invested Capital (ROIC)	-30.23%	-61.37%	2788.37%	-166.20%	-123.45%	-112.84%
Return on Capital Employed (ROCE)	-30.60%	-27.00%	146.70%	92.50%	949.40%	3316.20%
Earnings Yield	-5.97%	-2.96%	36.60%	-2.52%	-5.21%	-6.97%
FCF Yield	-7.76%	-6.35%	41.37%	2.55%	-4.02%	-2.48%
Dividend Yield	25.76%	22.19%	13.27%	-	-	-
Buyback Yield / Dilution	-	-	-	-0.25%	-1.25%	-9.87%
Total Shareholder Return	24.71%	22.19%	13.27%	-0.25%	-1.25%	-9.87%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.